as 05-20-2024 12:31pm EST
Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.
Founded: | 1944 | Country: | United States |
Employees: | N/A | City: | INDIANAPOLIS |
Market Cap: | 125.2B | IPO Year: | N/A |
Target Price: | $584.57 | AVG Volume (30 days): | 971.2K |
Analyst Decision: | Strong Buy | Number of Analysts: | 15 |
Dividend Yield: | 1.19% | Dividend Payout Frequency: | Quarterly |
EPS: | 26.49 | EPS Growth: | 4.87 |
52 Week Low/High: | $412.00 - $547.99 | Next Earning Date: | 07-17-2024 |
Revenue: | $171,745,000,000 | Revenue Growth: | 6.89% |
Revenue Growth (this year): | 1.6% | Revenue Growth (next year): | 5.82% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Norwood Felicia F | ELV | EVP & President,Gov Health Ben | Apr 23 '24 | Sell | $532.68 | 3,434 | $1,829,223.12 | 27,304 | SEC Form 4 |
Norwood Felicia F | ELV | EVP & President,Gov Health Ben | Apr 23 '24 | Sell | $532.14 | 2,765 | $1,471,367.10 | 30,738 | SEC Form 4 |
Norwood Felicia F | ELV | EVP & President,Gov Health Ben | Apr 23 '24 | Sell | $534.74 | 100 | $53,474.00 | 31,460 | SEC Form 4 |
Norwood Felicia F | ELV | EVP & President,Gov Health Ben | Apr 23 '24 | Sell | $533.73 | 14,011 | $7,478,091.03 | 31,560 | SEC Form 4 |
PERU RAMIRO G | ELV | Director | Feb 7 '24 | Sell | $500.00 | 753 | $376,500.00 | 9,109 | SEC Form 4 |
Todt Blair Williams | ELV | EVP, CLO & CAO | Dec 14 '23 | Sell | $484.02 | 5,492 | $2,658,237.84 | 12,512 | SEC Form 4 |
Penczek Ronald W | ELV | CAO & Controller | Nov 30 '23 | Sell | $475.17 | 1,055 | $501,304.35 | 1,787 | SEC Form 4 |
ELV Breaking Stock News: Dive into ELV Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
Zacks
10 days ago
Simply Wall St.
10 days ago
Zacks
11 days ago
GlobeNewswire
11 days ago
Simply Wall St.
14 days ago
Simply Wall St.
18 days ago
Zacks
19 days ago